Articles citing this article

The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).

Cited article:

Factors Influencing Unfractionated Heparin Pharmacokinetics and Pharmacodynamics During a Cardiopulmonary Bypass

Audrick Gibert, Julien Lanoiselée, Isabelle Gouin-Thibault, Adeline Pontis, Kasra Azarnoush, Andranik Petrosyan, Nathalie Grand, Serge Molliex, Jérome Morel, Laurent Gergelé, Sophie Hodin, Valérie Bin, Robin Chaux, Xavier Delavenne and Edouard Ollier
Clinical Pharmacokinetics 63 (2) 211 (2024)
https://doi.org/10.1007/s40262-023-01334-3

Infective Endocarditis Is a Risk Factor for Heparin Resistance in Adult Cardiovascular Surgical Procedures: A Retrospective Study

Yoshikazu Kimura, Shuji Okahara, Kanae Abo, Yusuke Koyama, Mitsuhito Kuriyama, Kazumi Ono and Hidekuni Hidaka
Journal of Cardiothoracic and Vascular Anesthesia 35 (12) 3568 (2021)
https://doi.org/10.1053/j.jvca.2021.05.024

Changes in heparin dose response slope during cardiac surgery: possible result in inaccuracy in predicting heparin bolus dose requirement to achieve target ACT

Junko Ichikawa, Tetsu Mori, Mitsuharu Kodaka, Keiko Nishiyama, Makoto Ozaki and Makiko Komori
Perfusion 32 (6) 474 (2017)
https://doi.org/10.1177/0267659117692661

In vitro and in vivo effects of hemodilution on kaolin-based activated clotting time predicted heparin requirement using a heparin dose–response technique

Junko Ichikawa, Satoshi Hagihira, Testu Mori, Mitsuharu Kodaka, Keiko Nishiyama, Makoto Ozaki and Makiko Komori
Journal of Anesthesia 30 (6) 923 (2016)
https://doi.org/10.1007/s00540-016-2227-9

Heparin dose adjustment required to maintain goal-activated partial thromboplastin time during therapeutic hypothermia

Ryan T. Fevold, Yuk Ting Lydia Leung, Adrian C. Garofoli, Roger D. White, Gregory W. Barsness, Ross A. Dierkhising and Narith N. Ou
Journal of Critical Care 30 (3) 574 (2015)
https://doi.org/10.1016/j.jcrc.2015.01.016

The Influence of Sampling Technique on ACT Plus® Results

Monique E. Brouwer, Ramen Miraziz, Grace Agbulos, Rona Steel, Peter Hales and Peter Klineberg
The Journal of ExtraCorporeal Technology 44 (4) 194 (2012)
https://doi.org/10.1051/ject/201244194

Measurement of Activated Coagulation Time in Children: Evaluation of the Blood-Saving Kaolin i-STAT Activated Coagulation Time Technique in Pediatric Cardiac Anesthesia

Francis F. Ulmer, Werner Baulig, Dominique Béttex, Nelly Spielmann, Christoph Bürki and Markus Weiss
Journal of Cardiothoracic and Vascular Anesthesia 25 (3) 395 (2011)
https://doi.org/10.1053/j.jvca.2010.12.014

Correlations Between Activated Clotting Time Values and Heparin Concentration Measurements in Young Infants Undergoing Cardiopulmonary Bypass

Nina A. Guzzetta, Heather G. Monitz, Janet D. Fernandez, Tom M. Fazlollah, Andrea Knezevic and Bruce E. Miller
Anesthesia & Analgesia 111 (1) 173 (2010)
https://doi.org/10.1213/ANE.0b013e3181e13470

A Comparison of Heparin Management Strategies in Infants Undergoing Cardiopulmonary Bypass

Nina A. Guzzetta, Tanya Bajaj, Tom Fazlollah, Fania Szlam, Elizabeth Wilson, Anna Kaiser, Steven R. Tosone and Bruce E. Miller
Anesthesia & Analgesia 106 (2) 419 (2008)
https://doi.org/10.1213/01.ane.0000297290.03501.db

Heparin resistance and the potential impact on maintenance of therapeutic coagulation

G. J. Despotis, M. Avidan and J. H. Levy
European Journal of Anaesthesiology 24 (Supplement 40) 37 (2007)
https://doi.org/10.1097/00003643-200706002-00003

Anticoagulation management in patients undergoing open heart surgery by activated clotting time and whole blood heparin concentration

Pappalardo Federico, Franco Annalisa, Crescenzi Giuseppe, De Simone Francesco, Torracca Lucia and Zangrillo Alberto
Perfusion 21 (5) 285 (2006)
https://doi.org/10.1177/0267659106074770

Urban Myths and the ACT: What is Not True and What Really Matters When it Comesto Monitoring Anticoagulation

Bruce Searles
The Journal of ExtraCorporeal Technology 38 (1) 56 (2006)
https://doi.org/10.1051/ject/200638056

Monitoring high-dose heparin levels by ACT and HMT during extracorporeal circulation: diagnostic accuracy of three compact monitors

Davide Giavarina, Mariarosa Carta, Alessandro Fabbri, Jacopo Manfredi, Edoardo Gasparotto and Giuliano Soffiati
Perfusion 17 (1) 23 (2002)
https://doi.org/10.1191/0267659102pf530oa

Evaluation of a new point of care heparin test for cardiopulmonary bypass: the TAS heparin management test

Michael Wallock, Walter P Jeske, Mamdouh Bakhos and Jeanine M Walenga
Perfusion 16 (2) 147 (2001)
https://doi.org/10.1177/026765910101600209

An Investigation of a New Activated Clotting Time “MAX-ACT” in Patients Undergoing Extracorporeal Circulation

Galina Leyvi, Linda Shore-Lesserson, Donna Harrington, Frances Vela-Cantos and Sabera Hossain
Anesthesia & Analgesia 92 (3) 578 (2001)
https://doi.org/10.1213/00000539-200103000-00005

An Investigation of a New Activated Clotting Time “MAX-ACT” in Patients Undergoing Extracorporeal Circulation

Galina Leyvi, Linda Shore-Lesserson, Donna Harrington, Frances Vela-Cantos and Sabera Hossain
Anesthesia & Analgesia 92 (3) 578 (2001)
https://doi.org/10.1097/00000539-200103000-00005

Optical Detection of Polycations via Polymer Film-Modified Microtiter Plates:  Response Mechanism and Bioanalytical Applications

Sheng Dai, Qingshan Ye, Enju Wang and Mark E. Meyerhoff
Analytical Chemistry 72 (14) 3142 (2000)
https://doi.org/10.1021/ac000060n

Management of anticoagulation and its reversal during paediatric cardiopulmonary bypass: a review of current UK practice

Massimiliano Codispoti and Pankaj S Mankad
Perfusion 15 (3) 191 (2000)
https://doi.org/10.1177/026765910001500303

Bioanalytical applications of polyion-sensitive electrodes

S. Dai, J.M. Esson, O. Lutze, N. Ramamurthy, V.C. Yang and M.E. Meyerhoff
Journal of Pharmaceutical and Biomedical Analysis 19 (1-2) 1 (1999)
https://doi.org/10.1016/S0731-7085(98)00134-4

Heparin management test versus activated coagulation time during cardiovascular surgery: Correlation with anti-Xa activity

Jane C.K. Fitch, Kristin L.B. Geary, Gayle P. Mirto, Daniel W. Byrne and Roberta L. Hines
Journal of Cardiothoracic and Vascular Anesthesia 13 (1) 53 (1999)
https://doi.org/10.1016/S1053-0770(99)90174-X

Improved protamine-sensitive membrane electrode for monitoring heparin concentrations in whole blood via protamine titration§

Narayanan Ramamurthy, Narayan Baliga, Joyce A Wahr, Ulrich Schaller, Victor C Yang and Mark E Meyerhoff
Clinical Chemistry 44 (3) 606 (1998)
https://doi.org/10.1093/clinchem/44.3.606

In vitro effect of hemodilution on activated clotting time and high-dose thrombin time during cardiopulmonary bypass

Robert J. Huyzen, Willem van Oeveren, Feiyan Wei, Pieter Stellingwerf, Piet W. Boonstra and Y.J. Gu
The Annals of Thoracic Surgery 62 (2) 533 (1996)
https://doi.org/10.1016/0003-4975(96)00324-4

Age-related differences in heparin sensitivity and heparin-protamine interactions in cardiac surgery patients

Celia D'Errico, Jay R. Shayevitz and Sarah J. Martindale
Journal of Cardiothoracic and Vascular Anesthesia 10 (4) 451 (1996)
https://doi.org/10.1016/S1053-0770(05)80003-5

The impact of heparin concentration and activated clotting time monitoring on blood conservation

G.J. Despotis, J.H. Joist, C.W. Hogue, A. Alsoufiev, K. Kater, L.T. Goodnough, S.A. Santoro, E. Spitznagel, M. Rosenblum and D.G. Lappas
The Journal of Thoracic and Cardiovascular Surgery 110 (1) 46 (1995)
https://doi.org/10.1016/S0022-5223(05)80008-X

Heparin and antithrombin III levels during cardiopulmonary bypass: Correlation with subclinical plasma coagulation

Kazuhiro Hashimoto, Masaaki Yamagishi, Tatsuumi Sasaki, Masamichi Nakano and Hiromi Kurosawa
The Annals of Thoracic Surgery 58 (3) 799 (1994)
https://doi.org/10.1016/0003-4975(94)90752-8

Comparison of activated coagulation time and whole blood heparin measurements with laboratory plasma anti-Xa heparin concentration in patients having cardiac operations

G.J. Despotis, A.L. Summerfield, J.H. Joist, L.T. Goodnough, S.A. Santoro, E. Spitznagel, J.L. Cox and D.G. Lappas
The Journal of Thoracic and Cardiovascular Surgery 108 (6) 1076 (1994)
https://doi.org/10.1016/S0022-5223(94)70150-4

Response to heparinization in adults and children undergoing cardiac operations

Ferenc Horkay, Paul Martin, S.Mano Rajah and Duncan R. Walker
The Annals of Thoracic Surgery 53 (5) 822 (1992)
https://doi.org/10.1016/0003-4975(92)91444-E

Monitoring of coagulation status using thrombelastography during paediatric open heart surgery

P. Martin, F. Horkay, S. M. Rajah and D. R. Walker
International Journal of Clinical Monitoring and Computing 8 (3) 183 (1991)
https://doi.org/10.1007/BF01738891

The Value of Activated Coagulation Time in Monitoring Heparin Therapy During Extracorporeal Circulation

Stig Ottesen, Helge Stormorken and Kjell Hatteland
Scandinavian Journal of Thoracic and Cardiovascular Surgery 18 (2) 123 (1984)
https://doi.org/10.3109/14017438409102391

Increased heparin requirements with autotransfusion

Nagaprasadarao Mummaneni, Maher Istanbouli, Roque Pifarré and Adel A. El-Etr
The Journal of Thoracic and Cardiovascular Surgery 86 (3) 446 (1983)
https://doi.org/10.1016/S0022-5223(19)39160-3